SonoNeu
PrivateLast Round
Grant
Apr 7, 2026
Total Funding Raised
$5.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SonoNeu is a biotechnology company that develops non-invasive, drug-free therapeutic treatments using sonogenetics to modulate cellular activity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SonoNeu Comparables
Compare SonoNeu with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Surf Therapeutics | 64% | |
| Grey Matter Neurosciences | 61% | |
| Axoft | 59% | |
SonoNeu Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2026 |
SonoNeu Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARPA-H | Grant |
| General Inception | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
$5.2M grant round from ARPA-H and General Inception.
SonoNeu Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SonoNeu's valuation, stock price, and market status.